OPT logo

Opthea Limited (OPT)

Profile

Full Name

Opthea Limited

Ticker Symbol

OPT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Australia

IPO

October 16, 2020

Indexes

Not included

Website

http://opthea.com

Employees

33

Key Details

Price

$3.41(0.00%)

Market cap

$524.82M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$124.70K(+15.04% YoY)

Annual EPS

-$2.76(-7.17% YoY)

PE ratio

-

Next earnings date

Aug 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.41
OPT price is $3.41

30-Day Relative Volume

0.00
OPT 30-day relative volume is 0.00

Price Performance

Price Most recent change

0%
OPT {parameterFullLabel} has remained unchanged on Apr 15, 2025

Price YTD change

-13.19%
OPT price is down -13.19% since January 1st

Price 1-year change

-3.67%
OPT price is down -3.67% year-on-year

Price 3-year change

-42.69%
OPT price is down -42.69% over the past 3 years

Price Range

Price All-time high

$16.23
OPT price is currently -78.99% below its historical high of $16.23

Price 3-year low

$1.60
OPT price is currently +113.13% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$524.82M
OPT market capitalization is $524.82 million

Market cap 3-year change

+74.08%
OPT market capitalization is up +74.08% over the past 3 years

Market cap All-time high

$911.13M
OPT market capitalization is currently -42.40% below its historical high of $911.13 million

Market cap sector rank

70.23%
OPT market capitalization is higher than 70.23% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+71.1%
OPT shares outstanding is up +71.1% year-on-year

Shares Outstanding 3-Year Change

+203.76%
OPT shares outstanding is up +203.76% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.61
OPT beta is 0.61

200-day SMA

$3.60
OPT price is currently -5.41% below its 200-day simple moving average

50-day SMA

$4.05
OPT price is currently -15.90% below its 50-day simple moving average

RSI

39.39
OPT 14-day relative strength index is 39.39

Volume

0.00
OPT 30-day relative volume is 0.00

ATR

$0.07
OPT average true range is $0.07

10-day Historical Volatility

0.00%
OPT 10-day historical volatility is 0.00%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$124.70K
OPT annual revenue is $124.70 thousand

Revenue Analysts estimate

$291.46K
OPT annual revenue is currently -57.22% lower than the consensus analysts' forecast

Revenue 1-year change

+15.04%
OPT annual revenue is up +15.04% year-on-year

Revenue Sector rank

5.7%
OPT annual revenue is higher than 5.7% of companies in Healthcare sector

EPS

EPS

-$2.76
OPT annual earnings per share is -$2.76

EPS Analysts estimate

-
OPT annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-7.17%
OPT annual earnings per share is down -7.17% year-on-year

EPS Sector rank

31.9%
OPT annual earnings per share is higher than 31.9% of companies in Healthcare sector

Profit

Gross profit

-
OPT annual gross profit value is unknown

Gross margin

-
OPT annual gross profit margin value is unknown

Operating profit

-$191.84M
OPT annual operating income is -$191.84 million

Operating margin

-153.89K%
OPT annual operating profit margin is -153.89 thousand%

Net income

-$220.24M
OPT annual net profit is -$220.24 million

Net margin

-176.67K%
OPT annual net profit margin is -176.67 thousand%

Expenses

Total expenses

$191.97M
OPT annual total expenses is $191.97 million

Operating expenses

$191.97M
OPT annual total operating expenses is $191.97 million

Cost of goods sold

-
OPT annual cost of goods sold value is unknown

Selling, general & administrative expenses

$15.49M
OPT annual SGA is $15.49 million

Depreciation and amortization

$103.00K
OPT annual depreciation & amortization is $103.00 thousand

Interest expense

$30.26M
OPT annual interest expense is $30.26 million

Income tax

-$9.41M
OPT annual income tax is -$9.41 million

EBIT & EBITDA

EBIT

-$199.39M
OPT annual earnings before interest & taxes is -$199.39 million

EBITDA

-$199.29M
OPT annual EBITDA is -$199.29 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$188.79M
OPT annual total assets is $188.79 million

Non current assets

$598.70K
OPT annual long term assets is $598.70 thousand

Current assets

$188.19M
OPT annual total current assets is $188.19 million

Cash and cash equivalents

$172.47M
OPT annual cash & cash equivalents is $172.47 million

Accounts receivable

-
OPT annual accounts receivable value is unknown

Inventory

-
OPT annual inventory value is unknown

Liabilities

Total liabilities

$264.60M
OPT annual total liabilities is $264.60 million

Long term liabilities

$200.55M
OPT annual total long term liabilities is $200.55 million

Current liabilities

$64.06M
OPT annual total current liabilities is $64.06 million

Accounts payable

$38.06M
OPT annual accounts payable is $38.06 million

Debt

Total debt

$141.65M
OPT annual total debt is $141.65 million

Total debt 1-year change

+65.01%
OPT annual total debt is up +65.01% year-on-year

Long term debt

$141.55M
OPT annual long term debt is $141.55 million

Short term debt

$93.00K
OPT annual short term debt is $93.00 thousand

Equity & Capital

Shareholders equity

-$75.81M
OPT annual stockholders equity is -$75.81 million

Book value

-$75.81M
OPT annual book value is -$75.81 million

Retained earnings

-$579.70M
OPT annual retained earnings is -$579.70 million

Working capital

$124.14M
OPT annual working capital is $124.14 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$161.02M
OPT annual cash flow from operations is -$161.02 million

Cash from operations 1-year change

-33.5%
OPT annual cash flow from operations is down -33.5% year-on-year

Cash from investing

-$33.50K
OPT annual cash flow from investing activities is -$33.50 thousand

Cash from investing 1-year change

-52.27%
OPT annual cash flow from investing activities is down -52.27% year-on-year

Cash from financing

$243.73M
OPT annual cash flow from financing activities is $243.73 million

Cash from financing 1-year change

+45.7%
OPT annual cash flow from financing activities is up +45.7% year-on-year

CAPEX

CAPEX

$33.50K
OPT annual capital expenditures is $33.50 thousand

CAPEX 1-year change

+52.27%
OPT annual capital expenditures is up +52.27% year-on-year

Free Cash Flow

Free cash flow

-$161.05M
OPT annual free cash flow is -$161.05 million

Free cash flow 1-year change

-33.51%
OPT annual free cash flow is down -33.51% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
OPT annual gross profit margin value is unknown

Operating margin

-153.89K%
OPT annual operating profit margin is -153.89 thousand%

Net margin

-176.67K%
OPT annual net profit margin is -176.67 thousand%

ROA & ROE

ROA

-153.25%
OPT annual return on assets is -153.25%

ROE

290.52%
OPT annual return on equity is 290.52%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
OPT price to earnings ratio value is unknown

PE ratio Sector rank

-
OPT price to earnings ratio is unknown

PB Ratio

PB ratio

-3.11
OPT price to book ratio is -3.11

PB ratio Sector rank

5.43%
OPT price to book ratio is higher than 5.43% of companies in Healthcare sector

PS Ratio

PS ratio

-
OPT price to sales ratio value is unknown

PS ratio Sector rank

-
OPT price to sales ratio is unknown

Enterprise value

Enterprise value

$550.15M
OPT enterprise value is $550.15 million

Enterprise value Sector rank

70.22%
OPT enterprise value is higher than 70.22% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
OPT EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
OPT EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.94
OPT annual current ratio is 2.94

Quick ratio

-
OPT annual quick ratio value is unknown

Leverage

Debt to equity

-1.87
OPT annual debt to equity ratio is -1.87

Interest coverage ratio

-6.59
OPT annual interest coverage ratio is -6.59

Risk & Stability

Piotroski F-Score

-
OPT piotroski f-score value is unknown

Altman Z-Score

-5.80
OPT altman z-score is -5.80

Analyst ratings

Recent major analysts updates

Mar 25, 25 Leerink Partners
Market Perform
Mar 25, 25 Jefferies
Underperform
Mar 25, 25 HC Wainwright & Co.
Neutral
Feb 28, 25 HC Wainwright & Co.
Buy
Jan 29, 25 HC Wainwright & Co.
Buy
Sep 3, 24 HC Wainwright & Co.
Buy
Sep 13, 23 Oppenheimer
Outperform
Aug 1, 23 HC Wainwright & Co.
Buy
May 16, 23 EF Hutton
Buy
Apr 17, 23 EF Hutton
Buy

Institutional Ownership

Similar stocks

OFIX logo
Orthofix Medical (OFIX)
QURE logo
uniQure NV (QURE)
ARVN logo
Arvinas (ARVN)
KIDS logo
OrthoPediatrics (KIDS)
KROS logo
Keros Therapeutics (KROS)
IMTX logo
Immatics NV (IMTX)
PRTA logo
Prothena (PRTA)
OMI logo
Owens & Minor (OMI)
BVS logo
Bioventus (BVS)
  • What is the ticker symbol for Opthea Limited?
  • Does Opthea Limited pay dividends?
  • What sector is Opthea Limited in?
  • What industry is Opthea Limited in?
  • What country is Opthea Limited based in?
  • When did Opthea Limited go public?
  • Is Opthea Limited in the S&P 500?
  • Is Opthea Limited in the NASDAQ 100?
  • Is Opthea Limited in the Dow Jones?
  • When was Opthea Limited's last earnings report?
  • When does Opthea Limited report earnings?
  • Should I buy Opthea Limited stock now?

What is the ticker symbol for Opthea Limited?

The ticker symbol for Opthea Limited is NASDAQ:OPT

Does Opthea Limited pay dividends?

No, Opthea Limited does not pay dividends

What sector is Opthea Limited in?

Opthea Limited is in the Healthcare sector

What industry is Opthea Limited in?

Opthea Limited is in the Biotechnology industry

What country is Opthea Limited based in?

Opthea Limited is headquartered in Australia

When did Opthea Limited go public?

Opthea Limited's initial public offering (IPO) was on October 16, 2020

Is Opthea Limited in the S&P 500?

No, Opthea Limited is not included in the S&P 500 index

Is Opthea Limited in the NASDAQ 100?

No, Opthea Limited is not included in the NASDAQ 100 index

Is Opthea Limited in the Dow Jones?

No, Opthea Limited is not included in the Dow Jones index

When was Opthea Limited's last earnings report?

Opthea Limited's most recent earnings report was on Aug 30, 2024

When does Opthea Limited report earnings?

The next expected earnings date for Opthea Limited is Aug 29, 2025

Should I buy Opthea Limited stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page